IL36A and inflammatory bowel disease: Functionally, IL-36 acted directly on human mesenchymal cells to elicit a profibrotic transcriptional program (298), suggesting that the increase of IL-36α+ Mfs could induce intestinal fibrosis during chronic inflammation in IBD patients (298–300).